Evidence map›Paper›PMID 41020590›Full record

ReviewmSphere2025

Viral apoptotic mimicry and the role of phosphatidylserine receptors.

Melinda A Brindley, Michael A Pisciotta

Abstract readReview
In one paragraph

Review in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Melinda A BrindleyDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.ORCID 0000-0002-4929-8085
Michael A PisciottaDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.

Funding

Defining the role of phosphatidylserine in hemorrhagic fever virus replicationR01AI139238 · NIAID · UNIVERSITY OF GEORGIA · PI BRINDLEY, MELINDA ANN · 2019 to 2023
$2.0M
T32 Predoctoral training grant in GlycosciencesT32GM145467 · NIGMS · UNIVERSITY OF GEORGIA · PI I JONATHAN AMSTER, Robert S. Haltiwanger · 2022 to 2026
$1.2M
National Institute of Allergy and Infectious Diseases R01AI139238NIAID NIH HHS R01 AI139238NIGMS NIH HHS T32 GM145467NIGMS NIH HHS T32GM145467
6 · The paper itself

Abstract

In our 2021 mSphere of Influence article (M. A. Brindley, mSphere 6:e00034-21, 2021, https://doi.org/10.1128/mSphere.00034-21), we discussed the concept of viral apoptotic mimicry and how the seminal study by Mercer and Helenius proposed a new paradigm in how viruses can gain entry into cells (J. Mercer and A. Helenius, Science 320:531-535, 2008, https://doi.org/10.1126/science.1155164). Building on the observation that enveloped viral lipids can mediate viral entry, subsequent studies have expanded these observations and further defined the lipids that can initiate infection, the cellular receptors involved, as well as started to explore how viruses obtain their membrane and potentially alter the lipid environment to enhance infection. Exploring the role viral apoptotic mimicry plays in the host has proven more difficult, as many of the receptors that interact with viral lipids also play key roles in immune signaling. This Full Circle review summarizes the lipids and receptors that are involved with viral apoptotic mimicry, the viruses that use them, as well as examines the studies that attempt to explore the role apoptotic mimicry plays in a host.

Indexed as

ApoptosisMolecular MimicryReceptors, Cell SurfaceVirusesVirus InternalizationAnimalsHost-Pathogen InteractionsHumansphosphatidylserine receptorReceptors, Cell Surfaceapoptotic mimicryphosphatidylserineTAMTIM-1

Identifiers

PMID41020590
PMCPMC12570474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.